Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities

Journal of Oral and Maxillofacial Surgery

Volumn 61, Issue 9, 2003, Pages 1022-1029

  Sigg, Martin Beat ^b   Steinert, Hans ^b   Grätz, Klaus ^b   Hugenin, Pia ^b   Stoeckli, Sandro ^b   Eyrich, Gerold Klaus ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEAD AND NECK TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STAGING; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

EID: 0042861631     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2391(03)00314-8     Document Type: Article

References (29)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics 1996. CA Cancer J Clin 46:5, 1996
2. Spitz MR: Epidemiology and risk factors for head and neck cancer. Semin Oncol 21:281, 1994
3. Vokes EE, Weichselbaum RR, Lippman SM, et al: Medical progress: Head and neck cancer. N Engl J Med 328:184, 1993
4. Mukherji SK, Mancuso AA, Kotzur IM, et al: Radiologic appearance of the irradiated larynx. Radiology 193:141, 1994
5. Di Martino E, Nowak B, Krombach GA, et al: Results of pretherapeutic lymph node diagnosis in head and neck tumors: Clinical value of 18-FDG positron emission tomography (PET). Laryngorhinootologie 79:201, 2000
6. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al: Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 36:1747, 1995
7. Stokkel MP, ten Broek FW, Hordijk GJ, et al: Preoperative evaluation of patients with head and neck cancer using dualhead 18fluorodeoxyglucose positron emission tomography. Ann Surg 231:229, 2000
8. Stokkel MP, Moons KG, ten Broek FW, et al: 18-F-Fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 86:2370, 1999
9. Keyes JW, Chen MY, Watson NE, et al: FDG PET evaluation of head and neck cancer: Value of imaging the thorax. Head Neck 22:105, 2000
10. 18F]fluorodeoxyglucose positron emission tomography method. Ann Neurol 6:371, 1979
11. Jabour BA, Choi Y, Hoh C, et al: Extracranial head and neckPET imaging with 2-[F-18] fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 186:27, 1993
12. Lindholm P, Minn H, Leskinen-Kallio S, et al: Influence of the blood glucose concentration on FDG uptake in cancer: A PET study. J Nucl Med 34:1, 1993
13. Kubota R, Yamada S, Kubota K, et al: Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. Nucl J Med 33:1972, 1992
14. Valk PE, Pounds TR, Tesar RD, et al: Cost effectiveness of PET imaging in clinical oncology. Nucl Med Biol 23:737, 1996
15. Di Martino E, Nowak B, Hassan HA, et al: Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 126:1457, 2000
16. Li P, Zhuang H, Mozley PD, et al: Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography. Clin Nucl Med 26:131, 2001
17. Lowe VJ, Boyd JH, Dunphy FR, et al: Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18:651, 2000
18. Hanasono MM, Kunda LD, Segall GM, et al: Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 109:880, 1999
19. Fischbein NJ, Aassar OS, Caputo GR, et al: Clinical utility of positron emission tomography with 18-F-fluorodeoxyglucose in detecting residual/ recurrent squamous cell carcinoma at the head and neck. AJNR Am J Neuroradiol 19:1189, 1998
20. Kunkel M, Kuffner HD, Reichert TE, et al: (18F)-2-Fluorodeoxyglucose PET: Prospects for secondary prevention of mouth cavity carcinoma. Mund Kiefer Gesichtschir 4:105, 2000
21. Lonneux M, Lawson G, Ide C, et al: Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 110:1493, 2000
22. Eichhorn T, Schroeder HG, Glanz H, et al: Histologically controlled comparison of palpation and sonography in the diagnosis of cervical lymph node metastases. Laryngol Rhinol Otol 66:266, 1987
23. Feinmesser R, Freeman JL, Feinmesser M, et al: Role of modern imaging in decision-making for elective neck dissection. Head Neck 14:173, 1992
24. Som PM: Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 156:961, 1992
25. Braams JW, Pruim J, Freling NJM, et al: Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 36:211, 1995
26. Manolidis S, Donald PJ, Volk P, et al: The use of positron emission tomography scanning in occult and recurrent head and neck cancer. Acta Otolaryngol (Stockh) Suppl 534:5, 1998
27. Haughey BH, Gates GA, Arfken CL, et al: Meta-analysis of second malignant tumors in head and neck cancer: The case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101:105, 1992
28. Adams S, Baum RP, Stuckensen T, et al: Prospective comparison of 18-F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255, 1998
29. Nowak B, Di Martino E, Janicke S, et al: Diagnostik maligner Kopf-Hals-Tumoren durch F-18-FDG PET im Vergleich zu CT/MRI. Nuklearmedizin 38:312, 1999